Sandip Agarwala serves as Executive at Talaris Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Sandip Agarwala has executed 2 insider transactions totaling $4.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on May 11, 2021 involved purchasing 235,000 shares valued at $4.0M.
Sandip Agarwala currently holds 3,220,775 shares of Talaris Therapeutics, Inc. (TALS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sandip Agarwala has been a net buyer of TALS stock. They have purchased $4.0M and sold $0 worth of shares.
Sandip Agarwala's most recent insider trade was on May 11, 2021, when they purchased 235,000 shares at $17.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |